CDC Secretor

Principal Investigator: Dr. Lilly Immergluck, Dr. Margaret Cortese

Key Personnel: Elham Laghaie, Victoria Churchill, Shaaz Fareed

Objectives: To determine if secretor status has an impact on vaccine 'take' among children receiving the rotavirus vaccination. 

Summary: We will be enrolling 2 month old infants who are receiving their first dose of Rotavirus vaccine. An analysis will be completed to determine if a child's secretor status impacts their vaccine 'take' and their inherited immunity of the oral vaccine.